Showing all published months. Partner preview tables include up to 5 countries.
CSV orders from USD 9.90 ยท One-time purchase. Review coverage and your total before payment.
USD value by month, all available partner countries combined
Free partner preview shows up to 5 countries.
Total value across the selected data period
| Partner | Value | Share |
|---|---|---|
| Japan | $1.2B | 25.0% |
| Hong Kong | $690.2M | 14.1% |
| South Korea | $684.5M | 14.0% |
| Taiwan | $563.6M | 11.5% |
| Vietnam | $465.2M | 9.5% |
Availability is confirmed when the API response loads.
| Partner | Value | Share |
|---|---|---|
| Japan | $13.6M | 27.5% |
| Hong Kong | $10.3M | 20.7% |
| Taiwan | $9.1M | 18.3% |
| South Korea | $5.8M | 11.7% |
| Malaysia | $2.1M | 4.3% |
| Year | Export value |
|---|---|
| 2021 | $863.8M |
| 2022 | $886.3M |
| 2023 | $888M |
| 2024 | $886.5M |
| 2025 | $840.4M |
| 2026 | $520.3M |
China customs reports HS 121190 at the 8-digit level. 30 subheadings are published under it, and export values for each are available on request.
Dried roots and related parts of the angelica sinensis plant, valued primarily in pharmaceutical manufacturing for their active medicinal compounds.
Pharmaceutical-grade pseudoginseng roots, processed and utilized chiefly as a therapeutic ingredient in traditional and modern medicine.
Codonopsis roots designated for pharmacy use, serving as a medicinal botanical ingredient often substituted for ginseng in therapeutic preparations.
Coptis rhizomes intended primarily for pharmaceutical applications, prized for their high alkaloid content and strong antibacterial medicinal properties.
Chrysanthemum flowers harvested for pharmacy use, providing medicinal botanical material commonly processed into therapeutic extracts and herbal formulations.
Cordyceps sinensis fungal specimens directed chiefly toward pharmaceutical use, classified as a highly valued medicinal organism for therapeutic preparations.
Bulbs of Fritillaria thunbergii used primarily in pharmaceutical applications, distinguished from other medicinal plant parts by their specific bulb morphology.
Rhizomes of Ligusticum utilized primarily for pharmaceutical purposes, classified according to their specific rootstock structure rather than bulb or taproot forms.
Pinellia rhizomes serving primarily pharmaceutical uses, identified within this group by their distinct subterranean stem structure and specific botanical origin.
Pharmaceutical applications primarily drive the trade of these peony roots, specifically the lactiflora species, differentiated by their taproot rather than rhizome form.
Gastrodia rhizomes intended primarily for pharmacy, recognized by their specialized subterranean stem format and distinct medicinal profile among related botanical parts.
Astragalus roots employed primarily in pharmaceutical contexts, set apart by their specific taproot structure and botanical source from the rhizome-based entries.
Rhubarb roots and parts designated for pharmaceutical applications are tracked here, distinguishing them from culinary varieties.
Pharmaceutical use of the rhizome from Atractylodes macrocephala, a traditional botanical, defines this specific line.
Rehmannia root material intended for pharmacy falls under this classification, separated from other medicinal roots.
Sophora flower parts processed for pharmaceutical purposes constitute the botanical material covered by this line.
Eucommia bark, harvested and prepared for pharmaceutical use, represents the distinct botanical subject of this entry.
Poria, a fungal sclerotium utilized in pharmacy, is the specific medicinal commodity classified within this subheading.
Dried goji berries, classified as fructus lycii, serve as pharmaceutical botanical ingredients rather than perfumery or pesticide materials.
Seeds of the bantaroi plant are specified here for their primary application in pharmaceutical manufacturing.
Resinous aloes wood is categorized under this heading for its predominant use in medicinal and pharmaceutical preparations.
Roots and parts of adenophora axilliflora are tracked for pharmaceutical use, distinguishing this medicinal herb from aromatic or pesticidal flora.
Pharmaceutical applications drive the classification of southernwood, setting it apart from any potential use in perfumery or pest control.
Liquorice roots are designated as pharmaceutical botanicals in this classification, excluding varieties processed for confectionery or flavoring.
Dried roots of the Astragalus plant, valued primarily in traditional pharmaceutical preparations for their active medicinal properties.
Flowers and leaves harvested from the linden tree, serving mainly as pharmaceutical ingredients for their calming and therapeutic qualities.
Botanical materials applied chiefly in pharmaceutical manufacturing, encompassing various flora not specifically enumerated elsewhere in the tariff schedule.
Floral and herbal components utilized predominantly as fragrance sources in perfumery, distinct from those directed toward medical or pesticidal applications.
Dessis roots and pyrethrum blossoms, both harvested specifically for their natural insecticidal properties and employed in producing botanical pest control agents.
Plant materials whose primary commercial application is insecticidal action, covering various botanical pest control sources beyond dessis roots and pyrethrum.
Public data shows up to 5 partner countries. Buy monthly partner trade values in CSV; choose HS8 for native quantity and unit fields where published.
CSV orders from USD 9.90 ยท One-time purchase. Confirm available coverage and your total in the order preview before paying.
Download after payment. Large packages may need preparation; delivery timing is confirmed before checkout.
Need help choosing products or regular updates? Ask us for a quote by email.
Sample files illustrate the delivery format. Preview your selected scope in the order builder.
HS 121190 is also written 1211.90. Values are in USD; the public series does not report tonnes or kg. Product scope: Botanical plant materials and parts used primarily in perfumery, pharmaceuticals, or as pesticides, covering flora not specifically classified elsewhere in the tariff schedule. The public page shows monthly export partner previews from official GACC customs statistics. Preview and buy a monthly CSV for your selected products, countries and years.
Source: China General Administration of Customs (GACC), cleaned and structured by China Data Portal.
Transformations: Values are presented as published by the source.
China Data Portal. "China Plants and parts of plants (HS 121190) Export Data." https://chinadata.live/china-trade/hs/121190/
China exported $837M of plants and parts of plants in the twelve months to August 2026, averaging $69.8M per month, based on official China customs statistics (HS 121190).
Botanical plant materials and parts used primarily in perfumery, pharmaceuticals, or as pesticides, covering flora not specifically classified elsewhere in the tariff schedule.
Japan, Hong Kong and South Korea together account for 53% of the published total, out of 80 trading partners on record.
Annual exports declined by 3% between 2021 and 2025, from $864M to $840M.
Figures come from official China General Administration of Customs (GACC) statistics, published monthly. ChinaData cleans partner names, periods and values so the series is ready for analysis. Partner-level rows for every month, including HS8 detail, are available as a one-time CSV purchase. Choose your products and coverage, then preview the file and price before payment.